Biotech · Private company
Biodexa Pharmaceuticals
Track this companyFree. Adds Biodexa Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MTX110Phase 1 · Recurrent GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Programmable pump and catheter systemPhase 1 · Recurrent GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase 3 Trial of eRapa in Patients With Familial Adenomatous PolyposisPHASE3 · RECRUITING · started Jul 18, 2025ClinicalTrials.gov NCT06950385 · fetched Nov 12, 2026
- A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent GlioblastomaPHASE1 · TERMINATED · started Oct 19, 2022ClinicalTrials.gov NCT05324501 · fetched Nov 12, 2026
- Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active SurveillancePHASE2 · COMPLETED · started Jan 18, 2021ClinicalTrials.gov NCT04230499 · fetched Nov 12, 2026